 |
Catumaxomab |
|---|---|
| Trade Name | Removab |
| Orphan Indication | Ovarian cancer |
| USA Market Approval | USA |
| USA Designation Date | 2006-06-09 00:00:00 |
| Sponsor | Neoviibiotech North America, Inc.;920 Winter Street;Waltham, Massachusetts, 02451 |
| |
Catumaxomab |
|---|---|
| Trade Name | Removab |
| Orphan Indication | Ovarian cancer |
| USA Market Approval | USA |
| USA Designation Date | 2006-06-09 00:00:00 |
| Sponsor | Neoviibiotech North America, Inc.;920 Winter Street;Waltham, Massachusetts, 02451 |